Intensive course:‘Model-based drug development: Incorporating population variability into mechanistic prediction of PK and modelling PK-PD' This event runs from 4th – 8th March 2013 at the Crowne Plaza Century Park, Shanghai, China.Delegates will learn how to simulate:• Metabolic drug clearance (CL)
• Metabolic drug-drug interactions (DDIs)
• Gut first-pass metabolism
• Oral drug absorption incorporating food effects and the impact of dosage form
• Effect of transporters and enterohepatic recirculation on kinetics and DDIs
• Drug distribution to different organs
• Population variability in drug concentration-time profiles
• Variation in kinetics in specific populations (paediatrics, ethnic groups, various disease populations)
• Data for therapeutic proteins
• Pharmacodynamic effects of different compounds
• Time-course of drug in plasma that fits observed clinical data (achieved by combining fitting techniques with IVIVE, PBPK and drug specific in vitro data)Click here to download the workshop flyer.Registration:

Online booking for Simcyp events is now handled through the Simcyp Members’ Area. Your saved profile is automatically captured on the booking form so there is no need to re-enter your contact details. Click here to link to the booking forms – you will be prompted for your Simcyp Members’ Area user name (email address) and password. If you have forgotten your log-in credentials please follow the instructions on-screen.If you have not yet registered for the Members’ Area please sign up now.For further information on any of Simcyp's events please contact Kelly Turton.Language AssistanceOur expert course tutors include many fluent Chinese speakers who will be able to assist with small group discussions and translate questions and answers after the lecture sessions. **Please note that the lectures and all course material will be in English**For Details Please Visitwww.simcyp.com/ProductServices/Workshops/20130304_Shanghai.htm?p=1

，而抗原提呈细胞表达B7.1和B7.2配体，两者相结合后，T细胞活性会下降。Tremelimumab与CTLA-4结合可以组织其与B7配体相结合，从而抑制B7-CTLA-4所介导的T细胞活性下降。B7.1或B7.2可以专心地跟T细胞表面CD28结合，诱发B7-CD28介导的T细胞活化，不受B7-CTLA-4介导的免疫抑制所干

近日，来自的 European Heart Journal 编辑部的 Ronald K. Binder 等从平衡出血和缺血风险的角度详细总结了双联抗血小板治疗（DAPT），本文为该文的简要总结。1. 支架表面血小板激活和聚集是导致支架内血栓形成的主要机制。DAPT 已经成为经皮冠状动脉介入治疗（PCI）后的基石

K.M. Stavropoulos进行了一项研究，研究结果显示，孤独症儿童对非社会性刺激的回应要高于社会性刺激。该研究结果最近发表在Journal

早期筛查和早期强化治疗能为新诊断2型糖尿病患者带来多少益处仍有争议。为此，来自丹麦奥胡斯大学的Sandbæk教授及其团队进行了一项研究，在筛查检出的2型糖尿病患者中，探讨多因素治疗对糖尿病微血管并发症的益处。该研究结果在线发表在线发表在2014年05月08日的Diabetes care杂志

麻省理工学院1月6日，亿万富翁船王Daniel K. Ludwig创立的信托基金投下了一枚“重磅炸弹”。6家美国医学中心收到了来自该基金总额为5.4亿美元的奖金（每个机构获9000万美元）。该基金旨在永久资助癌症研究——直到癌症不再是医学上的

了解更多信息，请点击：http://www.biomart.cn/upload/asset/2015/03/18/B1426231791.pdf

成熟淋巴细胞明显增多，表现为B-LPD的疾病，并不总是CLL！！

前无明显诱因出现右下腹隐痛, 呈阵发性, 无伴恶心呕吐, 伴肛门停止排气排便, 无伴大便习惯改变, 于当地医院查 B 超示：「右下腹包块, 伴有少量腹腔积液... 结节, 考虑转移瘤；③多发子宫肌瘤（图 60-1）。初步分析患者中年女性, 以「反复右下腹隐痛 20 天, 发现腹部包块 10 余天」入院, 结合患者 B 超

界的大咖们红光满面、载歌载舞，一打听，才知道这是为 27 日晚上 CSCO 二十周年庆典晚会想看完整的演出？9 月 27 日 20:00 - 22:00，B2 鹭江厅等你来！最后，想告诉你的是，CSCO 期间丁香园也来到了会场～我们的展台在 C2 展厅 B65，欢迎来展台逛逛，参加小活动就能赢取丁香园定制小礼物哦～